Dear Potential Offeror,

Thank you for your interest in USAID/Mozambique’s Adapting and Modifying Optimized Sample Transport Routes for Achieving Impact (AMOSTRA). The purpose of this communication is to obtain industry comment on the attached DRAFT Statement Of Objective (SOO). To that end, information obtained through this RFI will be held in confidence and will not be disclosed to the public unless specifically requested by responding sources.

The U.S. Agency for International Development (USAID), Integrated Health Office (IHO) seeks information to improve the terms of reference for outsourcing transportation system for laboratory specimens including viral load for HIV patients on antiretroviral therapy (ART) HIV Early Infant Diagnosis (Eid) and tuberculosis (TB) specimens. This RFI is intended to:

- Obtain details concerning partner community interest in the IHO’s anticipated requirement described herein;
- Obtain information on the level of capacity of potential local and locally established partners relative to the tasks and objectives described in this RFI titled “Adapting and Modifying Optimized Sample Transport Routes for Achieving (AMOSTRA)”;
- Solicit and obtain input, advice, knowledge, and best practices from organizations interested in participating.

While we welcome any comments you may have, we ask that if you chose to respond, that you answer the following questions to assist USAID: